Search
forResearch 5 of 22
- Cutaneous Adverse Events in Patients with Chronic Hepatitis C during Treatment with Directly Acting Antiviral Agents: A cohort study
- Alopecia areata after hepatitis C virus infection treatment: a case report
- Betulinic acid exerts anti‐hepatitis C virus activity via the suppression of NF‐κB‐ and MAPK‐ERK1/2‐mediated COX‐2 expression
- Drug repositioning approach to target viral and host cells in terms of COVID-19 treatment: A review of in vivo experiments and clinical studies
- Reporting on Adverse Clinical Events
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →